Mainz Biomed (MYNZ) Shares Outstanding (Weighted Average) (2020 - 2025)
Historic Shares Outstanding (Weighted Average) for Mainz Biomed (MYNZ) over the last 6 years, with Q2 2025 value amounting to $3.1 million.
- Mainz Biomed's Shares Outstanding (Weighted Average) rose 46275.68% to $3.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.1 million, marking a year-over-year increase of 46275.68%. This contributed to the annual value of $968234.0 for FY2024, which is 13844.72% up from last year.
- Mainz Biomed's Shares Outstanding (Weighted Average) amounted to $3.1 million in Q2 2025, which was up 46275.68% from $968234.0 recorded in Q4 2024.
- Mainz Biomed's Shares Outstanding (Weighted Average)'s 5-year high stood at $16.0 million during Q3 2023, with a 5-year trough of $353937.0 in Q4 2022.
- For the 5-year period, Mainz Biomed's Shares Outstanding (Weighted Average) averaged around $7.8 million, with its median value being $7.2 million (2021).
- Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first crashed by 9622.55% in 2024, then soared by 46275.68% in 2025.
- Over the past 5 years, Mainz Biomed's Shares Outstanding (Weighted Average) (Quarter) stood at $7.2 million in 2021, then plummeted by 95.09% to $353937.0 in 2022, then rose by 14.73% to $406058.0 in 2023, then surged by 138.45% to $968234.0 in 2024, then soared by 224.76% to $3.1 million in 2025.
- Its Shares Outstanding (Weighted Average) was $3.1 million in Q2 2025, compared to $968234.0 in Q4 2024 and $558751.0 in Q2 2024.